Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Hypertension Research

• Publication date

  2009-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/hr.2009.131PMID 19713965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Angiotensin II Type 1 Receptor Blocker on Blood Pressure Variability and Cardiovascular Remodeling in Hypertensive Patients on Chronic Peritoneal Dialysis

  2009cited by this paper
• Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis.

  2009cited by this paper
• Ambulatory Blood Pressure Monitoring and All-Cause Mortality in Elderly People With Diabetes Mellitus

  2009cited by this paper
• Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes.

  2009cited by this paper
• Reduction of proteinuria with angiotensin receptor blockers

  2008cited by this paper
• Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.

  2008cited by this paper
• Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension.

  2008cited by this paper
• UKPDS—modelling of cardiovascular risk assessment and lifetime simulation of outcomes

  2008cited by this paper
• Association of microalbuminuria with brachial-ankle pulse wave velocity: the Ohasama study.

  2008cited by this paper
• Ambulatory Blood Pressure and Heart Rate in Hypertensives with Renal Failure: Comparison between Diabetic Nephropathy and Non-Diabetic Glomerulopathy

  2008cited by this paper
• A Possible Relationship of Nocturnal Blood Pressure Variability with Coronary Artery Disease in Diabetic Nephropathy

  2007cited by this paper
• Long-Term Prognostic Value of Blood Pressure Variability in the General Population: Results of the Pressioni Arteriose Monitorate e Loro Associazioni Study

  2007cited by this paper
• Relationship between base blood pressure during sleep and health-related quality of life in healthy adults

  2007cited by this paper
• Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan.

  2007cited by this paper
• Ambulatory blood pressure, blood pressure variability and the prevalence of carotid artery alteration: the Ohasama study

  2007cited by this paper
• Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

  2006cited by this paper
• Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort.

  2006cited by this paper
• AT1 receptor antagonist restores cardiac ryanodine receptor function, rendering isoproterenol-induced failing heart less susceptible to Ca2+ -leak induced by oxidative stress.

  2006cited by this paper
• Thrombotic Microangiopathy in Malignant Hypertension and Hemolytic Uremic Syndrome (HUS)/Thrombotic Thrombocytopenic Purpura (TTP): Can We Differentiate One from the Other?

  2005cited by this paper
• Efficacy and Duration of Action of the Four Selective Angiotensin II Subtype 1 Receptor Blockers, Losartan, Candesartan, Valsartan and Telmisartan, in Patients with Essential Hypertension Determined by Home Blood Pressure Measurements

  2005cited by this paper
• [The Ohasama study].

  2004cited by this paper
• Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

  2003cited by this paper
• Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement.

  2002cited by this paper
• Sympatholytic properties of several AT1-receptor antagonists in the isolated rabbit thoracic aorta

  2002cited by this paper
• Comparison of telmisartan versus losartan: meta-analysis of titration-to-response studies

  2002cited by this paper
• Stroke Prognosis and Abnormal Nocturnal Blood Pressure Falls in Older Hypertensives

  2001cited by this paper
• Angiotensin II Type 1 Receptor Blockers

  2001cited by this paper
• The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

  2001cited by this paper
• Non‐dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus

  2000cited by this paper
• Ambulatory Blood Pressure Monitoring and Organ Damage

  2000cited by this paper
• Prognostic Significance of Blood Pressure and Heart Rate Variabilities: The Ohasama Study

  2000cited by this paper
• Relationship Between Circadian Blood Pressure Patterns and Progression of Early Carotid Atherosclerosis: A 3-Year Follow-Up Study

  2000cited by this paper
• Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

  2000cited by this paper
• Autonomic nervous system activity in dipper and non-dipper essential hypertensive patients. What about sex differences?

  1999cited by this paper
• ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension

  1999cited by this paper
• Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects.

  1998cited by this paper
• Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study.

  1997cited by this paper
• Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder.

  1996cited by this paper
• Altered blood pressure profile, autonomic neuropathy and nephropathy in insulin-dependent diabetic patients.

  1996cited by this paper
• Neural Cardiovascular Regulation and 24‐Hour Blood Pressure and Heart Rate Variability

  1996cited by this paper
• Relationship Between the Circadian Rhythms of Blood Pressure and Sympathovagal Balance in Diabetic Autonomic Neuropathy

  1993cited by this paper
• Effect of Blocking Angiotensin II Receptor Subtype on Rat Sympathetic Nerve Function

  1992cited by this paper

• Three-Year Cardiovascular Outcomes of Telmisartan in Patients with Hypertension: An Electronic Health Record-Based Cohort Study.

  2024cites this paper
• Association of the protective effect of telmisartan on hearing loss among patients with hypertension

  2024cites this paper
• Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Indian Guideline 2024 by Association of Physicians of India and Indian College of Physicians.

  2024cites this paper
• KIDNEY TRANSPLANTATION AND KIDNEY DONATION DO NOT AFFECT SHORT-TERM BLOOD PRESSURE VARIABILITY

  2023cites this paper
• High plasma aldosterone concentration is associated with worse 24-h ambulatory blood pressure profile in patients with primary aldosteronism

  2023cites this paper
• Cardioprotective and Antifibrotic Effects of Low-Dose Renin–Angiotensin–Aldosterone System Inhibitors in Type 1 Diabetic Rat Model

  2023cites this paper
• Comparative efficacy and safety of fimasartan in patients with hypertension: A network meta‐analysis of randomized controlled trials

  2022cites this paper
• The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy

  2022cites this paper
• Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats With Diabetic Nephropathy by Promoting Autophagy

  2021cites this paper
• Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover Trial

  2021cites this paper
• Dapagliflozin does not affect short-term blood pressure variability in patients with type-2 diabetes mellitus.

  2020cites this paper
• Comparison of the Effect of Fimasartan versus Valsartan on Blood Pressure Variability in Acute Ischemic Stroke: A Double-Blind Randomized Trial

  2019cites this paper
• Two-day home blood pressure monitoring may offer an alternative to costlier methods

  2018cites this paper
• Blood pressure variability : measurement and clinical implications

  2017cites this paper
• Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes

  2016cites this paper
• Effect of One-Week Salt Restriction on Blood Pressure Variability in Hypertensive Patients with Type 2 Diabetes

  2016cites this paper
• Comparison of the Acute Antihypertensive Response to Telmisartan and Irbesartan in Spontaneously Hypertensive Rats

  2016cites this paper
• Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice

  2016cites this paper
• Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension

  2016cites this paper
• Drugs affecting blood pressure variability: an update.

  2014cites this paper
• Vérnyomás-variabilitás mérése és klinikai értéke

  2014cites this paper
• [Measurement of blood pressure variability and the clinical value].

  2014cites this paper
• Effects of Single Pill-Based Combination Therapy of Amlodipine and Atorvastatin on Within-Visit Blood Pressure Variability and Parameters of Renal and Vascular Function in Hypertensive Patients with Chronic Kidney Disease

  2014cites this paper
• Prognostic Value of Blood Pressure Variability and Average Blood Pressure Levels in Patients With Hypertension and Diabetes

  2013cites this paper
• Effects of telmisartan on proteinuria or albuminuria: a meta-analysis of randomized trials.

  2013cites this paper
• A meta-analysis of randomized trials of telmisartan versus losartan for reduction of ambulatory blood pressure

  2013cites this paper
• Beneficial effect of calcium channel blockers on home blood pressure variability in the morning in patients with type 2 diabetes

  2013cites this paper
• Prophylactic Resveratrol and Telmisartan Combination Ameliorates Experimentally-Induced Diabetic Nephropathy in Rats , Focus on the Pro-Sclerotic Cytokine , Transforming Growth Factor-ß 1 ( TGF-ß 1 )

  2013cites this paper
• Addition of Aliskiren to Angiotensin Receptor Blocker Improves Ambulatory Blood Pressure Profile and Cardiorenal Function Better than Addition of Benazepril in Chronic Kidney Disease

  2013cites this paper
• Angiotensin receptor blockers regulate the synchronization of circadian rhythms in heart rate and blood pressure

  2013cites this paper
• Overview of telmisartan for blood pressure reduction among angiotensin II receptor blockers: a meta-analysis of head-to-head randomized trials.

  2013cites this paper
• L/N-Type Calcium Channel Blocker Cilnidipine Added to Renin-Angiotensin Inhibition Improves Ambulatory Blood Pressure Profile and Suppresses Cardiac Hypertrophy in Hypertension with Chronic Kidney Disease

  2013cites this paper
• Blood Pressure Variability: Prognostic Value and Therapeutic Implications

  2013cites this paper
• The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease

  2013cites this paper
• Sympathoinhibition caused by orally administered telmisartan through inhibition of the AT1 receptor in the rostral ventrolateral medulla of hypertensive rats

  2012cites this paper
• Relationship of Ambulatory Blood Pressure and the Heart Rate Profile with Renal Function Parameters in Hypertensive Patients with Chronic Kidney Disease

  2012cites this paper
• Questionable link between normo- to microalbuminuria and home-measured blood pressure variability in hypertension

  2012cites this paper
• Associations Between Day-by-Day Variability in Blood Pressure Measured at Home and Antihypertensive Drugs: The J-HOME-Morning Study

  2012cites this paper
• Telmisartan in the management of diabetic nephropathy: a contemporary view.

  2012cites this paper
• Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure Lowering: Amlodipine and Candesartan Trial in Yokohama (ACTY)

  2012cites this paper
• Effects of Aliskiren‐Based Therapy on Ambulatory Blood Pressure Profile, Central Hemodynamics, and Arterial Stiffness in Nondiabetic Mild to Moderate Hypertensive Patients

  2012cites this paper
• Blood Pressure Variability, Cardiovascular Risk, and Risk for Renal Disease Progression

  2012cites this paper
• Emerging concept of antihypertensive therapy based on ambulatory blood pressure profile in chronic kidney disease

  2011cites this paper
• Effects of Multiple Factorial Intervention on Ambulatory BP Profile and Renal Function in Hypertensive Type 2 Diabetic Patients with Overt Nephropathy – A Pilot Study

  2011cites this paper
• Effects of telmisartan and losartan on cardiovascular protection in Japanese hypertensive patients

  2011cites this paper
• The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus

  2011cites this paper
• Emerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney disease.

  2011cites this paper
• Day-by-day home-measured blood pressure variability: another important factor in hypertension with diabetic nephropathy?

  2011cites this paper
• Local renin-angiotensin system and the brain--a continuous quest for knowledge.

  2011cites this paper
• Diurnal blood pressure variation and sympathetic activity

  2010cites this paper
• Effects of Telmisartan on Arterial Stiffness Assessed by the Cardio-Ankle Vascular Index in Hypertensive Patients

  2010cites this paper
• Renovascular and renoprotective properties of telmisartan: clinical utility

  2010influential citation
• International Journal of Nephrology and Renovascular Disease

  year unknowncites this paper